en

PRODUCT DETAIL

Imraldi 40 mg injekčný roztok v naplnenom pere

Code 9720C
MA number EU/1/17/1216/005
Product Form: sol inj 1x0,8 ml/40 mg (pero napl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB04 Adalimumab
Shelf life: 42
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 24.08.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 22.01.2024
eu-flag.png sk-flag.png